BUFFALO GROVE, Illinois, January 29 /PRNewswire/ --

- Net Revenue of US$31.0 million; Net Income of US$5.3 million for the Quarter

Eagle Test Systems, Inc. (Nasdaq: EGLT), a provider of automated test equipment solutions for high-performance analog, mixed-signal and radio frequency (RF) semiconductors, announced financial results for its first fiscal quarter ended December 31, 2007.

Operating Results

LONDON, January 29 /PRNewswire/ --

Polarion Software, creators of fully integrated application lifecycle management solutions and services based on Subversion, will launch two workshop series in the United Kingdom: How to Ramp Up to Subversion Fast and Application Lifecycle Management with Subversion.

LONDON, January 29 /PRNewswire/ -- At ISE 2008, specialist UK distributor of 'Advanced Products', PSCo, is announcing a partnership deal with Minicom Advanced Systems, a leader in the development of advanced multimedia signal distribution systems for digital signage.

The partnership deal gives PSCo customers access to leading-edge technology for the transmission of video, audio and RS232 control signals, delivering high resolution, high performance content distribution for digital signage applications. Minicom Advanced Systems enable high quality images and audio to be transmitted over long distances, making it an extremely powerful digital signage solution.

NORCROSS, Georgia, January 29 /PRNewswire/ --

- Initiative Provides a New Way to Shop for Baby Products, With Information on the Best Baby Products and Easy-To-Follow Links to Major Retailers as Well

NORCROSS, Georgia, January 29 /PRNewswire/ --

BabySupply.Info, has launched today their new website, http://www.babysupply.info. The comprehensive website offers new parents an opportunity to save time and money with a shopping comparison engine for baby products and more.

NEW YORK, January 29 /PRNewswire/ --

- Organizations Worldwide Leverage SAML 2.0 Liberty Federation to Enable New Business Services, Help Meet Regulatory Requirements and Provide Users with Better Protection Against Online Fraud and Identity Theft

TORONTO, January 29 /PRNewswire/ -- Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody therapeutics focused on cancer, announced today it intends to explore strategic alternatives to further advance and realize value from its pipeline of therapeutic antibodies, its antibody discovery platform and its antibody manufacturing capabilities. The Company will consider potential strategic opportunities including, but not limited to, the sale or merger of the Company with another entity, and has retained HSBC to act as advisors in this process.